Chau, W K

c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling. [electronic resource] - Oncogene May 2013 - 2767-81 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1476-5594

10.1038/onc.2012.290 doi


ATP Binding Cassette Transporter, Subfamily G, Member 2
ATP-Binding Cassette Transporters--metabolism
Animals
Antineoplastic Agents--pharmacology
Benzamides--pharmacology
Cell Hypoxia
Cell Line, Tumor
Cell Proliferation--drug effects
Cell Survival--drug effects
Cell Transformation, Neoplastic--genetics
Cisplatin--pharmacology
Drug Resistance, Neoplasm--genetics
Female
Gene Expression Regulation, Neoplastic
Humans
Imatinib Mesylate
Mice
Mice, Inbred BALB C
Mice, Nude
Neoplasm Proteins--metabolism
Neoplastic Stem Cells--drug effects
Ovarian Neoplasms--drug therapy
Paclitaxel--pharmacology
Piperazines--pharmacology
Protein Kinase Inhibitors--pharmacology
Proto-Oncogene Proteins c-kit--genetics
Pyrimidines--pharmacology
RNA Interference
RNA, Small Interfering
Tumor Microenvironment
Wnt Proteins--metabolism
Wnt Signaling Pathway--drug effects
Xenograft Model Antitumor Assays
beta Catenin--metabolism